TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15615325

Group type: EXPERIMENTAL
Intervention: Just breakfast
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Just lunch
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both lunch and breakfast
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: No meal at all
Number of subjects: 10
Study: 11398073

Group type: EXPERIMENTAL
Intervention: Grass pollen immunotherapy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 9244032

Group type: EXPERIMENTAL
Intervention: ondansetron 8 mg
Number of subjects: 124

Group type: COMPARATOR
Intervention: metoclopramide 10 mg
Number of subjects: 124

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 124
Study: 8490411

Group type: EXPERIMENTAL
Intervention: Patients' recall of information immediately after signing the consent form
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Cognitive function
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: IQ
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Health locus of control
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Operation information cards
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Written information
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Patients not reading the consent form before signing
Number of subjects: 265
Study: 2824707

Group type: EXPERIMENTAL
Intervention: High-dose cyclophosphamide (1,200 mg/m2), doxorubicin (70 mg/m2), and vincristine (1 mg/m2) (HDCAV)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Conventional-dose cyclophosphamide (1,000 mg/m2), doxorubicin (40 mg/m2), and vincristine (1 mg/m2) (CDCAV)
Number of subjects: 298
Study: 29615792

Group type: EXPERIMENTAL
Intervention: Aerobic and resistance training for 16 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study: 26150093

Group type: EXPERIMENTAL
Intervention: Computer-facilitated 5As (CF-5As) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no CF-5As intervention)
Number of subjects: 0
Study: 25130289

Group type: EXPERIMENTAL
Intervention: Cefozopran (CZOP) 100mg/kg/day
Number of subjects: 64

Group type: COMPARATOR
Intervention: Cefepime (CFPM) 100mg/kg/day
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 64
Study: 22672334

Group type: EXPERIMENTAL
Intervention: Cultured allogeneic keratinocyte sheets
Number of subjects: 59

Group type: COMPARATOR
Intervention: Vaseline gauze (Control)
Number of subjects: 59
Study: 20347922

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (80mJ/2Hz) at 4mm with cooling
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (80mJ/2Hz) at 4mm without cooling
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (80mJ/2Hz) at 8mm with cooling
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (80mJ/2Hz) at 8mm without cooling
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (80mJ/2Hz) at 16mm with cooling
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Er:YAG laser (80mJ/2Hz) at 16mm without cooling
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 84
Study: 18555063

Group type: EXPERIMENTAL
Intervention: Anxiety sensitivity (AS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control for sex and negative affectivity
Number of subjects: 0
Study: 16209961

Group type: EXPERIMENTAL
Intervention: Adenosine group
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Group 2 (ECG and SPECT techniques)
Number of subjects: 166
Study: 11785996

Group type: EXPERIMENTAL
Intervention: Integrated heart failure management programme
Number of subjects: 197

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 197
Study: 10522954

Group type: EXPERIMENTAL
Intervention: EX1 (1 day per week)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: EX2 (2 days per week)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: EX3 (3 days per week)
Number of subjects: 46

Group type: COMPARATOR
Intervention: CO (Control group)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: All exercise groups (EX1, EX2, EX3)
Number of subjects: 46
Study: 10155051

Group type: EXPERIMENTAL
Intervention: Aerosolized albuterol and cromolyn sulfate
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Home aerosol treatments after intramuscular injection of dexamethasone
Number of subjects: 246
Study: 1362189

Group type: EXPERIMENTAL
Intervention: Norgestimate-containing OC
Number of subjects: 2197
Study: 6369456

Group type: EXPERIMENTAL
Intervention: Chlorpropamide (single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31259617

Group type: EXPERIMENTAL
Intervention: Exergame intervention (EG) for 24 weeks, 120 minutes per week, divided into two sessions of 60 minutes each.
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Exergame intervention (EG)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 55
Study: 29456937

Group type: EXPERIMENTAL
Intervention: Autologous incus (Group A)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Titanium prosthesis (Group B)
Number of subjects: 88
Study: 24549033

Group type: EXPERIMENTAL
Intervention: 1-year school-based intervention program
Number of subjects: 465

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 465
Study: 22075273

Group type: EXPERIMENTAL
Intervention: Walnut-enriched diet (48 g/d for 4 days)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo diet
Number of subjects: 15
Study: 19412190

Group type: EXPERIMENTAL
Intervention: Topical nitroglycerin formulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment options
Number of subjects: 0
Study: 17244294

Group type: EXPERIMENTAL
Intervention: Cash and Counseling (treatment group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medicaid services as usual (control group)
Number of subjects: 0
Study: 15197669

Group type: COMPARATOR
Intervention: Double lumen tube (DLT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Arndt bronchial blocker (BB)
Number of subjects: 32
Study: 11967497

Group type: EXPERIMENTAL
Intervention: Continuous combined hormone replacement therapy (E(2)/NETA)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166

Group type: COMPARATOR
Intervention: E(2)/NETA vs Placebo
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: E(2)/NETA vs Tibolone
Number of subjects: 166

Group type: COMPARATOR
Intervention: Tibolone vs Placebo
Number of subjects: 166
Study: 9717036

Group type: EXPERIMENTAL
Intervention: 2 mg sublingual 17 beta-oestradiol
Number of subjects: 12

Group type: COMPARATOR
Intervention: 2.5 mg buccal nitroglycerine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7816519

Group type: COMPARATOR
Intervention: Healthy children (control group), n = 7
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Children with Zellweger syndrome (ZS)
Number of subjects: 7
Study: 3400639

Group type: EXPERIMENTAL
Intervention: AST-120 (3.2 to 7.2 g/d) administered for 2.4 to 30.1 months (mean 13.2 +/- 7.4 months)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no AST-120)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: AST-120 (3.2 to 7.2 g/d)
Number of subjects: 51
Study: 29419341

Group type: EXPERIMENTAL
Intervention: Self-reported tobacco use
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Self-reported marijuana use
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Self-reported use of other substances (heroin, cocaine, opiates, oxycodone, benzodiazepines, methamphetamine, phencyclidine, barbiturates)
Number of subjects: 207
Study: 28490394

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 26038252

Group type: EXPERIMENTAL
Intervention: Alcohol management intervention
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 88
Study: 23775967

Group type: EXPERIMENTAL
Intervention: ETV prophylactic group (n = 41)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (n = 39)
Number of subjects: 80
Study: 20202271

Group type: EXPERIMENTAL
Intervention: Multifactorial, interdisciplinary team approach to falls prevention
Number of subjects: 109
Study: 18226671

Group type: EXPERIMENTAL
Intervention: 91-day extended-regimen oral contraceptive (OC) with low-dose ethinyl estradiol (EE)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 16607146

Group type: EXPERIMENTAL
Intervention: Triple therapy (omeprazole, clarithromycin, amoxicillin for 10 days)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Quadruple therapy (omeprazole, amoxicillin, metronidazole, bismuth citrate for 10 days)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Successful eradication therapy
Number of subjects: 122
Study: 12565981

Group type: EXPERIMENTAL
Intervention: Wide local excision (WLE) and tamoxifen (T) 20 mg daily
Number of subjects: 236

Group type: COMPARATOR
Intervention: Modified radical mastectomy (MRM)
Number of subjects: 236
Study: 11004045

Group type: EXPERIMENTAL
Intervention: Enalaprilat 1.25 mg IV followed by multidose nicardipine 2 mg IV
Number of subjects: 42

Group type: COMPARATOR
Intervention: Enalaprilat 1.25 mg IV followed by labetalol 5 mg IV
Number of subjects: 42
Study: 8864334

Group type: EXPERIMENTAL
Intervention: Screening for asymptomatic ischemia using stress tests and ambulatory ECG
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Randomization for revascularization
Number of subjects: 1820

Group type: EXPERIMENTAL
Intervention: Angiographic evidence of coronary artery disease
Number of subjects: 1820
Study: 1562862

Group type: EXPERIMENTAL
Intervention: Traditional ECT with constant-voltage modified sine-wave stimuli (n = 17)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Modern, constant-current brief-pulse ECT (n = 14)
Number of subjects: 31
Study: 3863913

Group type: EXPERIMENTAL
Intervention: Flap design group 1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flap design group 2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Initial height of alveolar bone
Number of subjects: 30
Study: 31888742

Group type: EXPERIMENTAL
Intervention: FKB327 40 mg via prefilled syringe (PFS)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: FKB327 40 mg via auto-injector (AI)
Number of subjects: 195

Group type: COMPARATOR
Intervention: FKB327 40 mg via vial with disposable syringe
Number of subjects: 195
Study: 29198070

Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 14
Study: 26908949

Group type: EXPERIMENTAL
Intervention: PFO closure using Amplatzer PFO Occluder
Number of subjects: 107

Group type: COMPARATOR
Intervention: Medical management (control)
Number of subjects: 107
Study: 24158488

Group type: EXPERIMENTAL
Intervention: Microbicide gel adherence in women with ongoing partners
Number of subjects: 1757

Group type: EXPERIMENTAL
Intervention: Microbicide gel adherence in women with new partners
Number of subjects: 1757

Group type: EXPERIMENTAL
Intervention: Condom use in women with new partners
Number of subjects: 1757

Group type: EXPERIMENTAL
Intervention: Condom use in women with ongoing partners
Number of subjects: 1757

Group type: EXPERIMENTAL
Intervention: Use of both gel and condom in women with new partners
Number of subjects: 1757

Group type: EXPERIMENTAL
Intervention: Use of both gel and condom in women with ongoing partners
Number of subjects: 1757

Group type: EXPERIMENTAL
Intervention: High gel adherence in women with ongoing partners
Number of subjects: 1757

Group type: EXPERIMENTAL
Intervention: HIV incidence in women with new partners
Number of subjects: 1757

Group type: EXPERIMENTAL
Intervention: HIV incidence in women with ongoing partners
Number of subjects: 1757
Study: 22701339

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion at a target organ concentration of 2.0 ng/mL
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 30
Study: 20419581

Group type: EXPERIMENTAL
Intervention: Child-focused cognitive behavior therapy (CBT) plus parental anxiety management (PAM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Child-focused cognitive behavior therapy (CBT)
Number of subjects: 60
Study: 18948245

Group type: EXPERIMENTAL
Intervention: TENS therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (pharmacologic analgesia alone)
Number of subjects: 60
Study: 16161735

Group type: COMPARATOR
Intervention: 100% autogenous bone (control side)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 1:1 mixture of autogenous bone and corticocancellous pig bone particles (test side)
Number of subjects: 18
Study: 12380788

Group type: EXPERIMENTAL
Intervention: Cefepime
Number of subjects: 52

Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 52
Study: 10428130

Group type: EXPERIMENTAL
Intervention: Early restricted motion of the ankle in a below-the-knee brace for six weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional postoperative management with a cast for eight weeks
Number of subjects: 71
Study: 7755384

Group type: EXPERIMENTAL
Intervention: AO-90 (500-750 mL/day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: C/MF group (Amiparen, 600-800 mL/day)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups (AO-90 and C/MF)
Number of subjects: 53
Study: 2304739

Group type: EXPERIMENTAL
Intervention: Aspirin (1000 mg three times a day)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Glucamethacin (140 mg three times a day)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Aspirin and Glucamethacin
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59

Group type: COMPARATOR
Intervention: Aspirin, Glucamethacin, and Placebo
Number of subjects: 59
Study: 440850

Group type: EXPERIMENTAL
Intervention: Primary care program participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 31376194

Group type: EXPERIMENTAL
Intervention: P2post group (n = 408 players)
Number of subjects: 806

Group type: COMPARATOR
Intervention: Standard-11+ group (n = 398 players)
Number of subjects: 806
Study: 27996349

Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery (CAS)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional surgery (CONV)
Number of subjects: 54
Study: 24991946

Group type: EXPERIMENTAL
Intervention: D-dimer
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: P-selectin
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Microparticles
Number of subjects: 200

Group type: COMPARATOR
Intervention: D-dimer, P-selectin, and microparticles
Number of subjects: 200
Study: 23615154

Group type: EXPERIMENTAL
Intervention: Movement Music Therapy (MMT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (simple exercise program)
Number of subjects: 112
Study: 20407860

Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) programs
Number of subjects: 21
Study: 19075278

Group type: EXPERIMENTAL
Intervention: Immediate docetaxel (75 mg/m² on day 1 every 21 days, maximum of six cycles)
Number of subjects: 566

Group type: COMPARATOR
Intervention: Delayed docetaxel
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Immediate docetaxel
Number of subjects: 566
Study: 17088680

Group type: EXPERIMENTAL
Intervention: Metoclopramide before stress scan
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Metoclopramide before rest scan
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (no metoclopramide)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Metoclopramide (both stress and rest)
Number of subjects: 95
Study: 15510237

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg once daily
Number of subjects: 4325

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4325
Study: 12528546

Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 96

Group type: COMPARATOR
Intervention: Isoproterenol
Number of subjects: 96
Study: 9024172

Group type: EXPERIMENTAL
Intervention: 80 mg valsartan
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 8302672

Group type: EXPERIMENTAL
Intervention: Chloral hydrate 25 mg/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chloral hydrate 50 mg/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chloral hydrate 70 mg/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Chloral hydrate doses (25 mg/kg vs 70 mg/kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EMG amplitude
Number of subjects: 20
Study: 3119689

Group type: EXPERIMENTAL
Intervention: Budesonide (inhalant corticosteroid)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (single-dose pretreatment)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Terbutaline (single-dose pretreatment, beta 2-agonist)
Number of subjects: 13
Study: 31882009

Group type: EXPERIMENTAL
Intervention: Moderate physical activity (10,000 steps walking, 5-8 METs) with hypocaloric diet
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: High-intense physical activity (at least 70% of VO2max, >8 METs) with hypocaloric diet
Number of subjects: 117

Group type: COMPARATOR
Intervention: Hypocaloric diet only (no physical activity prescribed)
Number of subjects: 117
Study: 28359166

Group type: EXPERIMENTAL
Intervention: Having an exercise partner
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Help with household duties
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Being 'very much' satisfied with support
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Naming >2 supporters
Number of subjects: 436
Study: 26656783

Group type: EXPERIMENTAL
Intervention: Perampanel
Number of subjects: 0
Study: 24216399

Group type: EXPERIMENTAL
Intervention: Face Mask Removal (FMR)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Helmet Removal (HR)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Riddell Revolution IQ (RIQ) with Helmet Removal (HR)
Number of subjects: 22

Group type: COMPARATOR
Intervention: VSR4 with Helmet Removal (HR)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Inflated helmets (regardless of helmet type)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Deflated helmets (regardless of helmet type)
Number of subjects: 22
Study: 22575165

Group type: EXPERIMENTAL
Intervention: Rotamix IgY
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo IgY
Number of subjects: 54
Study: 20153700

Group type: EXPERIMENTAL
Intervention: Plastibell® circumcision (PD)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Dissection circumcision (DC)
Number of subjects: 125
Study: 17957213

Group type: EXPERIMENTAL
Intervention: Nicotine nasal spray
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline placebo nasal spray
Number of subjects: 30
Study: 15716253

Group type: EXPERIMENTAL
Intervention: Opening wedge osteotomy
Number of subjects: 35
Study: 12417369

Group type: EXPERIMENTAL
Intervention: High-dose vitamin intervention regimen (folic acid, vitamins B(6) and B(12))
Number of subjects: 3688

Group type: COMPARATOR
Intervention: Low-dose vitamin intervention regimen (folic acid, vitamins B(6) and B(12))
Number of subjects: 3688
Study: 10740521

Group type: EXPERIMENTAL
Intervention: Helium-neon diode laser (1.4 mw, 670 nm) for 30 seconds (fluence = 0.34 J/cm2)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control incisions (not specified)
Number of subjects: 58
Study: 7742759

Group type: EXPERIMENTAL
Intervention: Vancomycin prophylaxis (500 mg x 3 peri-operatively)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No vancomycin prophylaxis
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vancomycin prophylaxis
Number of subjects: 40
Study: 2045037

Group type: EXPERIMENTAL
Intervention: Tinidazole 2 g single oral dose
Number of subjects: 75

Group type: COMPARATOR
Intervention: Metronidazole 400 mg vaginal tablet (2 x 1) for five consecutive days
Number of subjects: 75
Study: 7049600

Group type: EXPERIMENTAL
Intervention: Surgery + radiotherapy + CCNU, vincristine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgery + radiotherapy + CCNU, vincristine, procarbazine
Number of subjects: 0
Study: 30006862

Group type: EXPERIMENTAL
Intervention: Propofol (group P)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sevoflurane (group S)
Number of subjects: 50
Study: 28389435

Group type: EXPERIMENTAL
Intervention: Gentle suprapubic cutaneous stimulation (Quick-Wee method)
Number of subjects: 344
Study: 25841136

Group type: EXPERIMENTAL
Intervention: 2500 UFH units
Number of subjects: 731

Group type: COMPARATOR
Intervention: 5000 UFH units
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Pooled population with 2500 UFH units
Number of subjects: 731

Group type: COMPARATOR
Intervention: Pooled population with 5000 UFH units
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Mean UFH dose difference
Number of subjects: 731
Study: 24373830

Group type: EXPERIMENTAL
Intervention: Closed-system (COS) PIVCs
Number of subjects: 1199

Group type: COMPARATOR
Intervention: Open-system (MOS) PIVCs
Number of subjects: 1199
Study: 21067893

Group type: EXPERIMENTAL
Intervention: Anterior capsule relaxing incisions with neodymium:YAG laser
Number of subjects: 84

Group type: COMPARATOR
Intervention: No capsulotomy (control group)
Number of subjects: 84
Study: 19807985

Group type: EXPERIMENTAL
Intervention: Original azelastine nasal spray, 2 sprays/nostril b.i.d.
Number of subjects: 835

Group type: EXPERIMENTAL
Intervention: Reformulated azelastine nasal spray, 2 sprays/nostril b.i.d.
Number of subjects: 835

Group type: COMPARATOR
Intervention: Placebo, 2 sprays/nostril b.i.d.
Number of subjects: 835

Group type: EXPERIMENTAL
Intervention: Original azelastine nasal spray, 1 spray/nostril b.i.d.
Number of subjects: 835

Group type: EXPERIMENTAL
Intervention: Reformulated azelastine, 1 spray/nostril b.i.d.
Number of subjects: 835
Study: 17702725

Group type: EXPERIMENTAL
Intervention: B cell‐driven treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard protocol of four weekly doses of 375 mg/m2
Number of subjects: 36
Study: 15500669

Group type: EXPERIMENTAL
Intervention: 20% SLS solution applied to scalp
Number of subjects: 10

Group type: COMPARATOR
Intervention: 20% SLS solution applied to back
Number of subjects: 10

Group type: COMPARATOR
Intervention: 20% SLS solution applied to arm
Number of subjects: 10
Study: 11413660

Group type: EXPERIMENTAL
Intervention: Gastric feeding
Number of subjects: 25

Group type: COMPARATOR
Intervention: Duodenal feeding
Number of subjects: 25